Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 84

Similar articles for PubMed (Select 18007564)

1.

Defining the clinical course of bipolar disorder: response, remission, relapse, recurrence, and roughening.

Hirschfeld RM, Calabrese JR, Frye MA, Lavori PW, Sachs G, Thase ME, Wagner KD.

Psychopharmacol Bull. 2007;40(3):7-14.

PMID:
18007564
2.

Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial.

Tohen M, Greil W, Calabrese JR, Sachs GS, Yatham LN, Oerlinghausen BM, Koukopoulos A, Cassano GB, Grunze H, Licht RW, Dell'Osso L, Evans AR, Risser R, Baker RW, Crane H, Dossenbach MR, Bowden CL.

Am J Psychiatry. 2005 Jul;162(7):1281-90.

PMID:
15994710
3.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
4.

Four-year prospective outcome and natural history of mania in children with a prepubertal and early adolescent bipolar disorder phenotype.

Geller B, Tillman R, Craney JL, Bolhofner K.

Arch Gen Psychiatry. 2004 May;61(5):459-67.

PMID:
15123490
5.

The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence.

Tohen M, Zarate CA Jr, Hennen J, Khalsa HM, Strakowski SM, Gebre-Medhin P, Salvatore P, Baldessarini RJ.

Am J Psychiatry. 2003 Dec;160(12):2099-107.

PMID:
14638578
6.

Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study.

Tohen M, Ketter TA, Zarate CA, Suppes T, Frye M, Altshuler L, Zajecka J, Schuh LM, Risser RC, Brown E, Baker RW.

Am J Psychiatry. 2003 Jul;160(7):1263-71.

PMID:
12832240
7.

Clinical characterization of depressive mixed state in bipolar-I patients: Pisa-San Diego collaboration.

Perugi G, Akiskal HS, Micheli C, Toni C, Madaro D.

J Affect Disord. 2001 Dec;67(1-3):105-14.

PMID:
11869757
8.

Subsyndromal depressive symptoms in patients with bipolar and unipolar disorder during clinical remission.

Vieta E, Sánchez-Moreno J, Lahuerta J, Zaragoza S; EDHIPO Group (Hypomania Detection Study Group).

J Affect Disord. 2008 Apr;107(1-3):169-74. Epub 2007 Sep 17.

PMID:
17870184
9.

Time to remission and relapse after the first hospital admission in severe bipolar disorder.

Bromet EJ, Finch SJ, Carlson GA, Fochtmann L, Mojtabai R, Craig TJ, Kang S, Ye Q.

Soc Psychiatry Psychiatr Epidemiol. 2005 Feb;40(2):106-13.

PMID:
15685401
10.

Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.

Benazzi F, Berk M, Frye MA, Wang W, Barraco A, Tohen M.

J Clin Psychiatry. 2009 Oct;70(10):1424-31. doi: 10.4088/JCP.08m04772gre.

PMID:
19906346
11.

Response to ECT in bipolar I, bipolar II and unipolar depression.

Medda P, Perugi G, Zanello S, Ciuffa M, Cassano GB.

J Affect Disord. 2009 Nov;118(1-3):55-9. doi: 10.1016/j.jad.2009.01.014. Epub 2009 Feb 14.

PMID:
19223079
12.

Baseline characteristics and outcomes in patients with first episode or multiple episodes of acute mania.

Tohen M, Vieta E, Gonzalez-Pinto A, Reed C, Lin D; European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) Advisory Board.

J Clin Psychiatry. 2010 Mar;71(3):255-61. doi: 10.4088/JCP.08m04580. Epub 2009 Aug 25.

PMID:
19709503
13.

[Clinical particularism of bipolar disorder: unipolar mania. About a patient's study in Tunesia].

Dakhlaoui O, Essafi I, Haffani F.

Encephale. 2008 Sep;34(4):337-42. doi: 10.1016/j.encep.2007.06.008. Epub 2007 Oct 26. French.

PMID:
18922234
14.

Why do clinicians maintain antidepressants in some patients with acute mania? Hints from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM), a large naturalistic study.

Rosa AR, Cruz N, Franco C, Haro JM, Bertsch J, Reed C, Aarre TF, Sanchez-Moreno J, Vieta E.

J Clin Psychiatry. 2010 Aug;71(8):1000-6. doi: 10.4088/JCP.09m05026gre. Epub 2010 Mar 23.

PMID:
20361912
15.

Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).

Perlis RH, Ostacher MJ, Patel JK, Marangell LB, Zhang H, Wisniewski SR, Ketter TA, Miklowitz DJ, Otto MW, Gyulai L, Reilly-Harrington NA, Nierenberg AA, Sachs GS, Thase ME.

Am J Psychiatry. 2006 Feb;163(2):217-24.

PMID:
16449474
16.

Bipolar II disorder : epidemiology, diagnosis and management.

Benazzi F.

CNS Drugs. 2007;21(9):727-40. Review.

PMID:
17696573
17.

Defining and achieving recovery from bipolar disorder.

Harvey PD.

J Clin Psychiatry. 2006;67 Suppl 9:14-8; discussion 36-42. Review.

PMID:
16965184
18.

Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12-week trial.

Bowden CL, Mosolov S, Hranov L, Chen E, Habil H, Kongsakon R, Manfredi R, Lin HN.

Int Clin Psychopharmacol. 2010 Mar;25(2):60-7. doi: 10.1097/YIC.0b013e328333ac1b.

PMID:
20101186
19.

Maintenance of response following stabilization of mixed index episodes with olanzapine monotherapy in a randomized, double-blind, placebo-controlled study of bipolar 1 disorder.

Tohen M, Sutton VK, Calabrese JR, Sachs GS, Bowden CL.

J Affect Disord. 2009 Jul;116(1-2):43-50. doi: 10.1016/j.jad.2008.11.003. Epub 2008 Dec 2.

PMID:
19054570
20.

Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine.

Tohen M, Calabrese JR, Sachs GS, Banov MD, Detke HC, Risser R, Baker RW, Chou JC, Bowden CL.

Am J Psychiatry. 2006 Feb;163(2):247-56.

PMID:
16449478
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk